247 related articles for article (PubMed ID: 9671328)
1. Anemia of cancer patients: patient selection and patient stratification for epoetin treatment.
Ludwig H; Fritz E
Semin Oncol; 1998 Jun; 25(3 Suppl 7):35-8. PubMed ID: 9671328
[TBL] [Abstract][Full Text] [Related]
2. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
3. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cancer-related anemia with epoetin alfa: a review.
Ferrario E; Ferrari L; Bidoli P; De Candis D; Del Vecchio M; De Dosso S; Buzzoni R; Bajetta E
Cancer Treat Rev; 2004 Oct; 30(6):563-75. PubMed ID: 15325036
[TBL] [Abstract][Full Text] [Related]
5. Epoetin alfa: into the new millennium.
Adamson JW
Semin Oncol; 1998 Jun; 25(3 Suppl 7):76-9. PubMed ID: 9671336
[TBL] [Abstract][Full Text] [Related]
6. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
8. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
Chang J; Couture F; Young S; McWatters KL; Lau CY
J Clin Oncol; 2005 Apr; 23(12):2597-605. PubMed ID: 15452188
[TBL] [Abstract][Full Text] [Related]
9. Prediction of response to optimize outcome of treatment with erythropoietin.
Beguin Y
Semin Oncol; 1998 Jun; 25(3 Suppl 7):27-34. PubMed ID: 9671327
[TBL] [Abstract][Full Text] [Related]
10. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
Chan A; Lim LL; Tao M
Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
[TBL] [Abstract][Full Text] [Related]
11. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
Crawford J; Cella D; Cleeland CS; Cremieux PY; Demetri GD; Sarokhan BJ; Slavin MB; Glaspy JA
Cancer; 2002 Aug; 95(4):888-95. PubMed ID: 12209734
[TBL] [Abstract][Full Text] [Related]
12. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
[TBL] [Abstract][Full Text] [Related]
13. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
Osterborg A; Brandberg Y
Cancer; 2003 Jun; 97(12):3125-6; author reply 3126-7. PubMed ID: 12784351
[No Abstract] [Full Text] [Related]
14. Epoetin alfa and high-dose chemotherapy.
Henry DH
Semin Oncol; 1998 Jun; 25(3 Suppl 7):54-7. PubMed ID: 9671332
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in pediatric oncology: a review.
Feusner J; Hastings C
Med Pediatr Oncol; 2002 Oct; 39(4):463-8. PubMed ID: 12203665
[TBL] [Abstract][Full Text] [Related]
16. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
17. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
18. Increased hemoglobin levels and improved quality-of-life assessments during epoetin alfa treatment in anemic cancer patients: results of a prospective, multicenter German trial.
Reinhardt U; Tulusan A; Angermund R; Lutz H;
Oncologist; 2005 Mar; 10(3):225-37. PubMed ID: 15793226
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
Wright JR; Ung YC; Julian JA; Pritchard KI; Whelan TJ; Smith C; Szechtman B; Roa W; Mulroy L; Rudinskas L; Gagnon B; Okawara GS; Levine MN
J Clin Oncol; 2007 Mar; 25(9):1027-32. PubMed ID: 17312332
[TBL] [Abstract][Full Text] [Related]
20. Management of chemotherapy-induced anemia in solid tumors.
Thatcher N
Semin Oncol; 1998 Jun; 25(3 Suppl 7):23-6. PubMed ID: 9671326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]